Dolgencorp, LLC Naproxen Sodium Capsules, 220 mg (NSAID) Drug Facts | dg health naproxen

Note: While we endeavour to keep our records up-to-date one should not rely on these details being accurate without first consulting a professional.

Naproxen sodium 220 mg (naproxen 200 mg) (NSAID)*

*nonsteroidal anti-inflammatory drug

Pain reliever/fever reducer

Allergy alert: Naproxen sodium may cause a severe allergic reaction, especially in people allergic to aspirin. Symptoms may include:

If an allergic reaction occurs, stop use and seek medical help right away.

Stomach bleeding warning: This product contains an NSAID, which may cause severe stomach bleeding. The chance is higher if you:

ask a health professional before use. It is especially important not to use naproxen sodium during the last 3 months of pregnancy unless definitely directed to do so by a doctor because it may cause problems in the unborn child or complications during delivery.

In case of overdose, get medical help or contact a Poison Control Center right away. (1-800-222-1222)

adults and children 12 years and older:	take 1 capsule every 8 to 12 hours while symptoms last for the first dose you may take 2 capsules within the first hour do not exceed 2 capsules in any 8- to 12 hour period do not exceed 3 capsules in a 24 hour period
children under 12 years:	ask a doctor

FD&C Blue #1, gelatin, glycerin, lactic acid, mannitol, pharmaceutical ink, polyethylene glycol, povidone, propylene glycol, purified water, sorbitan, sorbitol

1-888-309-9030

Naproxen Sodium Capsules, 220 mg (NSAID)

Pain Reliever/Fever Reducer

See New Warnings Information

Actual Size

**Liquid Filled Capsules

IMAGE 00051a01-1c2e-4abb-b04c-548401f822c6-01.jpg

IMAGE 00051a01-1c2e-4abb-b04c-548401f822c6-02.jpg

Manufacturer

Dolgencorp, LLC

Active Ingredients

Source

U.S. National Library of Medicine
DailyMed
Last Updated: 31st of January 2012

Medications 1480 Associated Medications

Mouth rinse
Drug Facts
Rx act naproxen sodium
HEB Naproxen Sodium Capsules, 220 mg (NSAID) Drug Facts
Naproxen sodium
Safeway Inc. Naproxen Sodium Capsules, 220 mg (NSAID) Drug Facts
Naproxen sodium
Kroger Co. Naproxen Sodium Capsules, 220 mg (NSAID) Drug Facts
Equate naproxen sodium
Wal-Mart Naproxen Sodium Capsules, 220 mg (NSAID) Drug Facts

Clinical Trials 2399 Associated Clinical Trials

Naproxen Sodium ER Pharmacokinetic Study
To determine the pharmacokinetic profile of the investigational product following dosing under fed conditions.
Bioequivalence Study of Naproxen Sodium 220 mg & Pseudoephedrine HCl 120 mg ER Tablets of Dr. Reddy's Under Fed Conditions
The purpose of this study is to assess the bioequivalence of Naproxen sodium 220 mg + Pseudoephedrine Hydrochloride 120 mg Extended Release tablets of with Aleve Cold and Sinus in healthy...
Fast & Fed Pharmacokinetic (PK) Study
The purpose of this study is to provide information on how well an extended release formulation (a medication that is released and absorbed over a longer period of time than a regular rele...
Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PN 200 or Naproxen in Subjects Who Are at Risk for Developing NSAID-Associated Ulcers.
The purpose of this study is to evaluate the incidence of gastric ulcers following administration of either PN 200 or Naproxen in subjects who are at risk for developing NSAID-associated u...
Pharmacokinetics Study Comparing Naproxen Sodium Extended Release and Naprelan
To compare the pharmacokinetic profile of the proposed extended- release tablet of naproxen sodium 660 mg relative to two tablets of Naprelan 500 mg following single dose administration fo...

PubMed Articles 8298 Associated PubMed Articles

Demographic, medical, and behavioral characteristics associated with over the counter non-steroidal anti-inflammatory drug use in a population-based cohort: results from the Multi-Ethnic Study of Atherosclerosis.
BACKGROUND: Three types of non-steroidal anti-inflammatory drugs (NSAIDs) can be obtained both over the counter (OTC) and by prescription in the United States. OTC NSAID use is not recorded in prescri...
Evaluation of the use of sumatriptan-naproxen sodium for menstrual migraine and dysmenorrhea.
Evaluation of: Cady RK, Diamond ML, Diamond MP et al. Sumatriptan-naproxen sodium for menstrual migraine and dysmenorrhea: satisfaction, productivity, and functional disability outcomes. Headache 51(5...
NO-releasing NSAIDs suppress NF-κB signaling in vitro and in vivo through S-nitrosylation.
NO-NSAIDs are promising anticancer drugs, comprising an NSAID, an NO-releasing moiety, and a spacer linking them. Although the effect of NO-NSAIDs on a wide variety of signaling and other cellular mec...
ASAS recommendations for collecting, analysing and reporting NSAID intake in clinical trials/epidemiological studies in axial spondyloarthritis.
The amount of NSAID intake could be considered as a clinically relevant outcome measure in ankylosing spondylitis. The information should include at least the following: (1) the type of NSAID; (2) the...
Gastrointestinal tolerability of NSAIDs in elderly patients: a pooled analysis of 21 randomized clinical trials with celecoxib and nonselective NSAIDs.
Abstract Background: Gastrointestinal (GI) tolerability is an important treatment consideration for physicians when choosing a nonselective nonsteroidal anti-inflammatory drug (NSAID) for their elderl...